Lurtotecan, a semi-synthetic analog of camptothecin, stabilizes the topoisomerase I-DNA complex, inhibiting DNA replication and causing apoptosis through the formation of an enzyme-drug-DNA ternary complex. It also disrupts RNA synthesis, promotes the degradation of topoisomerase I, and alters chromatin structure, making it useful in PROTAC development for targeted cancer treatments.
Usually ships within 24 hours.